1-4 of 4
Adrienne Nedved
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and without Pre-Transplant Exposure to Novel Agents

Ayo S Falade, Robert A. Redd, Harsh Shah, Kelsey Baron, Siddharth Iyengar, Sanjal H. Desai, Stephen M Ansell, Ivana Micallef, Adrienne Nedved, Nivetha Ganesan, Tiffany Chang, Gunjan L. Shah, Robert Stuver, Alison Moskowitz, Matthew Genyeh Mei, Tamer Othman, Shin Yeu Ong, Alex F. Herrera, Philippe Armand, Reid W. Merryman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3062.
https://doi.org/10.1182/blood-2023-182318
Published: 2023
Journal Articles

Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience

Arushi Khurana, Radhika Bansal, Matthew Hathcock, Adrienne Nedved, Yucai Wang, Jonas Paludo, Jose C Villasboas, N. Nora Bennani, Patrick B. Johnston, Stephen M. Ansell, Yi Lin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3842.
https://doi.org/10.1182/blood-2021-152313
Published: 2021
Journal Articles

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma

Mattia Novo, M Hasib Sidiqi, MBBS, Jonas Paludo, MD, Sangeetha Gandhi, MBBS, Jilan Kubusek, PharmD, Tuan Truong, Justin Hayne, Stephen M Ansell, MD PhD, N. Nora Bennani, MD, Jose C Villasboas, Adrienne Nedved, Pharm.D., R,Ph, Gina Lange, Eva Brandes, Hassan B. Alkhateeb, MD, David Dingli, MD PhD, Suzanne R. Hayman, MD, Prashant Kapoor, MD, Saad S. Kenderian, MD, Taxiarchis Kourelis, MD, Shaji K. Kumar, MD, Mithun Vinod Shah, MD PhD, Mustaqeem Siddiqui, MD, Rahma M Warsame, MD, Patrick Johnston, MD PhD, Yi Lin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4106.
https://doi.org/10.1182/blood-2019-127094
Published: 2019
Journal Articles

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Darci Zblewski, APRN, C-NP, Naseema Gangat, MBBS, Michelle A. Elliott, MD, Aref Al-Kali, MD, Mark R. Litzow, MD, C. Christopher Hook, MD, Tyler Mielke, Alexandra Wolanskyj, MD, Willam Hogan, MB, BCh, Animesh Pardanani, MBBS, PhD, Mithun Vinod Shah, MD PhD, Hassan B. Alkhateeb, MD, Lindsey Ann Kluck, MSN, NP, Adrienne Nedved, Pharm.D., R,Ph, Kristen McCullough, PharmD, Matthew Smith, Pharm.D., R.Ph, Tammy McAllister, M.A., Konstantinos Lazaridis, MD, A Keith Stewart, MB, ChB, Mrinal M. Patnaik, MD MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5440.
https://doi.org/10.1182/blood-2018-99-118600
Published: 2018